nach oben

Techniques in Coloproctology

Erschienen in:

01.02.2020 | Review

Anal squamous intraepithelial lesions: an update and proposed management algorithm

verfasst von: T. Chittleborough, R. Tapper, T. Eglinton, Frank Frizelle

Erschienen in: Techniques in Coloproctology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

The term anal squamous intraepithelial lesion (ASIL) is used to describe premalignant change of anal squamous cells that precede the development of squamous cell carcinoma. Pathophysiology is driven by the human papilloma virus (HPV), and progression and regression of ASIL being well described, with 12% of high-grade lesions progressing to invasive cancer within 5 years. Vaccination against HPV is effective for primary prevention. Management consists of identification and treatment of high-grade lesions to prevent progression to squamous cell carcinoma. Management of established ASIL aims to avoid the progression to invasive cancer and maintain fecal continence. A combination of surveillance, excision, ablative, or topical therapies is used to achieve this. The aim of the present study was to review the contemporary evidence about ASIL and to suggest a management algorithm.

Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA (2006) Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 76(8):715–717. https://doi.org/10.1111/j.1445-2197.2006.03837.x CrossRefPubMed

Sykes P, Smith N, McCormick P, Frizelle FA (2002) High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. Aust N Z J Obstet Gynaecol 42(1):69–74CrossRefPubMed

Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186–192CrossRefPubMed

Carter PS, Sheffield JP, Shepherd N, Melcher DH, Jenkins D, Ewings P, Talbot I, Northover JM (1994) Interobserver variation in the reporting of the histopathological grading of anal intraepithelial neoplasia. J Clin Pathol 47(11):1032–1034CrossRefPubMedPubMedCentral

Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC (2013) The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 32(1):76–115. https://doi.org/10.1097/PGP.0b013e31826916c7 CrossRefPubMed

Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, Markowitz LE (2011) Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 204(4):566–573. https://doi.org/10.1093/infdis/jir341 CrossRefPubMed

IARC (2007) Monographs on the evaluation of carcinogenic risks to humans, Human Papillomaviruses, vol 90. IARC Press, Lyon

De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124(7):1626–1636. https://doi.org/10.1002/ijc.24116 CrossRefPubMed

Murphy B (2017) Chief Medical Officer Letter - Changes to the National Cervical Screening Program (NCSP). http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/cmo-letter-changes-ncsp. Accessed 01 Apr 2019

10.

Grant J (2017) Future Directions for HPV and Cervical Screening: Metro Auckland Cervical Screening Forum. Metro Auckland Cervical Screening Forum. http://nationalwomenshealth.adhb.govt.nz/Portals/0/CervicalScreening/EveningForums/MACSForum.June.2017.pdf. Accessed 24 Feb 2019

11.

Roberts JR, Siekas LL, Kaz AM (2017) Anal intraepithelial neoplasia: a review of diagnosis and management. World J Gastrointest Oncol 9(2):50–61. https://doi.org/10.4251/wjgo.v9.i2.50 CrossRefPubMedPubMedCentral

12.

National Cancer Institute: Surveillance E, and End Results Program Cancer Stat Facts: Anal Cancer https://seer.cancer.gov/statfacts/html/anus.html. Accessed 17 Jun 2018

13.

Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, Templeton DJ, Grulich AE (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13(5):487–500. https://doi.org/10.1016/s1470-2045(12)70080-3 CrossRefPubMed

14.

Taylor S, Bunge E, Bakker M, Castellsague X (2016) The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infect Dis 16:293. https://doi.org/10.1186/s12879-016-1633-9 CrossRefPubMedPubMedCentral

15.

Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM (2001) Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 93(11):843–849CrossRefPubMed

16.

Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, Rogers K (1994) Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 81(3):365–367CrossRefPubMed

17.

Gautier M, Brochard C, Lion A, Henno S, Mallet AL, Bodere A, Bouguen G, Lievre A, Siproudhis L (2016) High-grade anal intraepithelial neoplasia: progression to invasive cancer is not a certainty. Dig Liver Dis 48(7):806–811. https://doi.org/10.1016/j.dld.2016.03.011 CrossRefPubMed

18.

Long KC, Menon R, Bastawrous A, Billingham R (2016) Screening, surveillance, and treatment of anal intraepithelial neoplasia. Clin Colon Rectal Surg 29(1):57–64. https://doi.org/10.1055/s-0035-1570394 CrossRefPubMedPubMedCentral

19.

Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Goodman MT (2009) Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis 48(5):536–546. https://doi.org/10.1086/596758 CrossRefPubMed

20.

Lee GC, Kunitake H, Milch H, Savitt LR, Stafford CE, Bordeianou LG, Francone TD, Ricciardi R (2018) What is the risk of anal carcinoma in patients with anal intraepithelial neoplasia III? Dis Colon Rectum 61(12):1350–1356. https://doi.org/10.1097/dcr.0000000000001219 CrossRefPubMedPubMedCentral

21.

Berry JM, Jay N, Cranston RD, Darragh TM, Holly EA, Welton ML, Palefsky JM (2014) Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer 134(5):1147–1155. https://doi.org/10.1002/ijc.28431 CrossRefPubMed

22.

Scholefield JH, Castle MT, Watson NF (2005) Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 92(9):1133–1136. https://doi.org/10.1002/bjs.4994 CrossRefPubMed

23.

Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, Berry JM, Jay N, Darragh TM (1998) Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 17(4):314–319CrossRefPubMed

24.

Patel HS, Silver AR, Northover JM (2007) Anal cancer in renal transplant patients. Int J Colorectal Dis 22(1):1–5. https://doi.org/10.1007/s00384-005-0023-3 CrossRefPubMed

25.

Patel HS, Silver AR, Levine T, Williams G, Northover JM (2010) Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg 97(11):1716–1721. https://doi.org/10.1002/bjs.7218 CrossRefPubMedPubMedCentral

26.

Burgos J, Curran A, Tallada N, Guelar A, Navarro J, Landolfi S, Villar J, Crespo M, Ribera E, Falco V (2015) Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM. AIDS 29(6):695–702. https://doi.org/10.1097/qad.0000000000000603 CrossRefPubMed

27.

de Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vezina S, Cote P, Macleod J, Allaire G, Hadjeres R, Franco EL, Coutlee F (2011) HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 52(9):1174–1181. https://doi.org/10.1093/cid/cir064 CrossRefPubMed

28.

Crum-Cianflone NF, Hullsiek KH, Marconi VC, Ganesan A, Weintrob A, Barthel RV, Agan BK (2010) Anal cancers among HIV-infected persons: HAARt is not slowing rising incidence. AIDS 24(4):535–543. https://doi.org/10.1097/QAD.0b013e328331f6e2 CrossRefPubMed

29.

Machalek DA, Jin F, Poynten IM, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE, on behalf of the Sst (2016) Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men. Papillomavirus Res 2:97–105. https://doi.org/10.1016/j.pvr.2016.05.003 CrossRefPubMedPubMedCentral

30.

Camus M, Lesage AC, Flejou JF, Hoyeau N, Atienza P, Etienney I (2015) Which lesions should be biopsied during high-resolution anoscopy? Prospective descriptive study of simple morphological criteria. J Low Genit Tract Dis 19(2):156–160. https://doi.org/10.1097/lgt.0000000000000064 CrossRefPubMed

31.

Richel O, Hallensleben ND, Kreuter A, van Noesel CJ, Prins JM, de Vries HJ (2013) High-resolution anoscopy: clinical features of anal intraepithelial neoplasia in HIV-positive men. Dis Colon Rectum 56(11):1237–1242. https://doi.org/10.1097/DCR.0b013e3182a53568 CrossRefPubMed

32.

Tomassi MJ, Abbas MA, Klaristenfeld DD (2019) Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience. Int J Colorectal Dis 34(1):47–54. https://doi.org/10.1007/s00384-018-3167-7 CrossRefPubMed

33.

Cajas-Monson LC, Ramamoorthy SL, Cosman BC (2018) Expectant management of high-grade anal dysplasia in people with HIV: long-term data. Dis Colon Rectum 61(12):1357–1363. https://doi.org/10.1097/dcr.0000000000001180 CrossRefPubMed

34.

Goldstone SE, Johnstone AA, Moshier EL (2014) Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer. Dis Colon Rectum 57(3):316–323. https://doi.org/10.1097/dcr.0000000000000058 CrossRefPubMed

35.

Johnstone AA, Silvera R, Goldstone SE (2015) Targeted ablation of perianal high-grade dysplasia in men who have sex with men: an alternative to mapping and wide local excision. Dis Colon Rectum 58(1):45–52. https://doi.org/10.1097/dcr.0000000000000241 CrossRefPubMed

36.

Berry JM, Palefsky JM, Jay N, Cheng S-C, Darragh TM, Chin-Hong PV (2009) Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 52(2):239–247. https://doi.org/10.1007/DCR.0b013e31819793d9 CrossRefPubMed

37.

Factor SH, Cooperstein A, Pereira GA, Goldstone SE (2014) Are colon and rectal surgeons ready to screen for anal dysplasia? Results of a survey on attitudes and practice. Sex Transm Dis 41(4):246–253. https://doi.org/10.1097/olq.0000000000000105 CrossRefPubMed

38.

Arain S, Walts AE, Thomas P, Bose S (2005) The Anal Pap Smear: cytomorphology of squamous intraepithelial lesions. Cytojournal 2(1):4. https://doi.org/10.1186/1742-6413-2-4 CrossRefPubMedPubMedCentral

39.

Fox PA, Seet JE, Stebbing J, Francis N, Barton SE, Strauss S, Allen-Mersh TG, Gazzard BG, Bower M (2005) The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 81(2):142–146. https://doi.org/10.1136/sti.2003.008318 CrossRefPubMedPubMedCentral

40.

Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM (1997) Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 14(5):415–422CrossRefPubMed

41.

Machalek DA, Poynten IM, Jin F, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE (2016) A composite cytology-histology endpoint allows a more accurate estimate of anal high-grade squamous intraepithelial lesion prevalence. Cancer Epidemiol Biomark Prev 25(7):1134–1143. https://doi.org/10.1158/1055-9965.epi-15-1106 CrossRef

42.

Panther LA, Wagner K, Proper J, Fugelso DK, Chatis PA, Weeden W, Nasser IA, Doweiko JP, Dezube BJ (2004) High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 38(10):1490–1492. https://doi.org/10.1086/383574 CrossRefPubMed

43.

Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383(9916):524–532. https://doi.org/10.1016/s0140-6736(13)62218-7 CrossRefPubMed

44.

Padilla-Espana L, Repiso-Jimenez JB, Fernandez-Sanchez F, Pereda T, Rivas-Ruiz F, Fernandez-Morano T, de la Torre-Lima J, Palma F, Redondo M, de Troya-Martin M (2016) Effectiveness of human papillomavirus genotyping for detection of high-grade anal intraepithelial neoplasia compared to anal cytology. Enferm Infecc Microbiol Clin 34(7):400–405. https://doi.org/10.1016/j.eimc.2016.02.003 CrossRefPubMed

45.

Cheng SH, Wang CC, Chang SL, Chu FY, Hsueh YM (2015) Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus. Int J Clin Oncol 20(5):943–951. https://doi.org/10.1007/s10147-015-0804-9 CrossRefPubMed

46.

Sambursky JA, Terlizzi JP, Goldstone SE (2018) Testing for human papillomavirus strains 16 and 18 helps predict the presence of anal high-grade squamous intraepithelial lesions. Dis Colon Rectum 61(12):1364–1371. https://doi.org/10.1097/dcr.0000000000001143 CrossRefPubMed

47.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM (2000) Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 108(8):634–641CrossRefPubMed

48.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM (1999) The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281(19):1822–1829CrossRefPubMed

49.

Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR, PoBotCPGCotASo Colon, Surgeons R (2018) The American Society of Colon and Rectal Surgeons clinical practice guidelines for anal squamous cell cancers (Revised 2018). Dis Colon Rectum 61(7):755–774. https://doi.org/10.1097/dcr.0000000000001114 CrossRefPubMed

50.

Fox PA, Nathan M, Francis N, Singh N, Weir J, Dixon G, Barton SE, Bower M (2010) A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod. AIDS 24(15):2331–2335. https://doi.org/10.1097/QAD.0b013e32833d466c CrossRefPubMed

51.

Richel O, de Vries HJ, van Noesel CJ, Dijkgraaf MG, Prins JM (2013) Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol 14(4):346–353. https://doi.org/10.1016/s1470-2045(13)70067-6 CrossRefPubMed

52.

Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EI (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365(17):1576–1585. https://doi.org/10.1056/NEJMoa1010971 CrossRefPubMed

53.

A5298 Protocol Team (2016) ACTG A5298: A phase 3 trial of the quadrivalent HPV vaccine in older HIV + Adults. In: Paper presented at the conference on retroviruses and opportunistic infections, Seattle, Washington,

54.

Miltz A, Price H, Shahmanesh M, Copas A, Gilson R (2014) Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure. PLoS One 9(3):e90348. https://doi.org/10.1371/journal.pone.0090348 CrossRefPubMedPubMedCentral

55.

Swedish KA, Factor SH, Goldstone SE (2012) Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 54(7):891–898. https://doi.org/10.1093/cid/cir1036 CrossRefPubMed

56.

Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB (2015) Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men. Clin Infect Dis 61(10):1527–1535. https://doi.org/10.1093/cid/civ628 CrossRefPubMedPubMedCentral

Titel: Anal squamous intraepithelial lesions: an update and proposed management algorithm
verfasst von: T. Chittleborough
R. Tapper
T. Eglinton
Frank Frizelle
Publikationsdatum: 01.02.2020
Verlag: Springer International Publishing
Erschienen in: Techniques in Coloproctology / Ausgabe 2/2020
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI: https://doi.org/10.1007/s10151-019-02133-4

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Chronic pelvic sepsis with pubic bone osteitis treated with double graciloplasty

Hemorrhoid laser procedure with suture-pexy (HeLPexx): a novel effective procedure to treat hemorrhoidal disease

Elective surgery for tumours of the splenic flexure: a French inter-group (AFC, SFCD, FRENCH, GRECCAR) survey

Evaluation and management of perianal abscess and anal fistula: SICCR position statement

Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases

Efficacy of Doppler-guided hemorrhoidal artery ligation with mucopexy, in the short and long terms for patients with hemorrhoidal disease

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“